Wegovy stopped working: why it happens and what to do next
After 6-12 months on Wegovy, some patients see weight loss stall or regain. The cause is rarely 'the drug stopped working' — it's biology, dose ceiling, or adherence. Here's how to diagnose what actually happened and the evidence-based moves.
2 min readUpdated
- ~0%
- STEP-1 mean weight loss at 68 weeks (Wegovy)
- 0-40%
- patients plateau before reaching 10% loss
- 0.0 mg
- Wegovy maximum approved dose
- ~0%
- tirzepatide max trial result (next-step option)
Jump to section
Diagnose what 'stopped working' actually means
Three distinct scenarios get lumped together as 'Wegovy stopped working': (1) you're at maintenance dose and weight has plateaued — this is the body defending its new set point, the drug is still doing its job; (2) you've regained 5-10% despite continued use — appetite signals are escaping the drug's effect, often around dose ceiling; (3) you never reached meaningful loss (<5% at 6 months on max dose) — true non-response, rare but real.
Plateau is the most common scenario by far and is not a treatment failure. The body's homeostatic systems adapt to lower weight by reducing resting energy expenditure and increasing appetite signals. Continued maintenance dosing prevents regain rather than driving further loss.
Evidence-based moves by scenario
If plateau at maintenance: focus on lean mass and metabolic health, not chasing more weight loss. Protein 1.2-1.6g/kg, resistance training 2-3x weekly, sleep, stress. Wegovy is doing the harder job — preventing regain. Most patients who try to push through plateau aggressively risk muscle loss and rebound.
If regain at maintenance: confirm adherence (missed doses? wrong refrigeration?), confirm injection technique (lipohypertrophy can reduce absorption), consider switching to tirzepatide (Zepbound) which has higher ceiling efficacy than semaglutide for ~30% of patients.
If never reached meaningful response (<5% at 6 months on max dose): true non-response. Discuss with prescriber: switching to tirzepatide first, then considering retatrutide trial enrollment, then bariatric surgery referral. Genetic responder/non-responder testing is not yet clinically useful but research is ongoing.
When to switch vs. when to escalate
Switch to tirzepatide if: you're at Wegovy max dose with <10% loss at 12 months and good adherence. Roughly 30-40% of semaglutide non-responders respond to tirzepatide due to GIP agonism added to GLP-1.
Wait it out (no switch) if: you've reached 8-15% loss and plateaued. This is the body's defended set point — pushing harder doesn't typically work and risks muscle loss.
Consider surgery referral if: max-dose Zepbound also fails (this is true treatment-resistant obesity, and bariatric surgery has 25-30% loss expectation).
Sources
Primary sources cited above. FDA labeling, peer-reviewed trials, and specialty-society guidelines only.
- STEP-1 Trial: Once-Weekly Semaglutide in Adults with Overweight or Obesity · New England Journal of Medicine, 2021 · PMID 33616314
- Tirzepatide vs Semaglutide Real-World Head-to-Head Outcomes · JAMA Internal Medicine, 2024
People also ask
Is Wegovy plateau the same as Wegovy not working?
No. Plateau at maintenance dose means the body has reached a new set point — Wegovy is preventing regain (its hardest job) but not driving further loss. True non-response means <5% weight loss at 6 months on max dose with good adherence.
Should I switch from Wegovy to Zepbound if I plateaued?
Maybe. If you've reached 10-15% loss and plateaued near a healthy weight, switching probably won't help and may worsen GI side effects. If you've plateaued early (<8% loss at max dose), 30-40% of patients respond to tirzepatide where semaglutide stalled.
Can I take a break from Wegovy and restart?
Most patients who pause Wegovy regain weight rapidly (50-70% of lost weight within 12 months). Restart works but you'll need to re-titrate from 0.25mg again. Brief breaks (<2 weeks) for tolerance reasons can be reasonable; longer breaks generally undo progress.
What's the maximum weight loss possible on Wegovy?
STEP-1 trial showed ~15% mean at 68 weeks but with wide individual variation: top responders (top 10%) reached 20-25%, bottom 10% reached <5%. Personal response depends on genetics, adherence, dose tolerated, and lifestyle factors.
If Wegovy stopped working, should I just stop taking it?
Almost never the right move. Discontinuation typically leads to weight regain regardless of whether the drug was 'working' for further loss. Either continue at maintenance (it's preventing regain) or switch to a different GLP-1 — but rarely stop without a plan.
Related reads
Wegovy prior authorization: the step-by-step approval playbook (2026)
Wegovy denials usually come from incomplete documentation, not clinical ineligibility. Here's the exact step-by-step process that gets approval on the first submission, plus what to do when denied.
GLP-1 hair loss timeline: when it starts, peaks, and recovers (2026)
Hair shedding on Wegovy, Ozempic, or Zepbound follows a predictable pattern tied to rapid weight loss, not the drug itself. Here's the week-by-week timeline, why it happens, and what actually shortens recovery.
Wegovy vs Ozempic in 2026: same drug, different prescribing rules
Wegovy and Ozempic are both semaglutide. Wegovy is FDA-approved for weight management; Ozempic for type 2 diabetes. Same active ingredient — but different dose, different insurance pathway, different cost, and different clinical conversation. Here's the full comparison.